Company intelligence / Profile preview

Stemform

Ownership: Private
Development stage: Commercial

Overview

Stemform offers natural breast augmentation and implant replacement using a patient's own stem cells, ensuring high graft retention rates and natural aesthetic results.

Therapeutic areas: Women's HealthDermatology
Modalities: Stem cells (specifically adipose tissue-derived stem/stromal cells)
Industry: Non-Drug Biotech

Drug pipeline

3 assets

Stemform BA

Commercial

Indications: Breast augmentation

2 more assets in the full pipeline.

Request access →

Partnerships

Collaborations with leading surgeons and hospitals

Beyond the preview

Go deeper on Stemform.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Stemform.

Explore the full profile